Holen Sie sich die Stockscreener-App
7.06
5.11%
-0.38
Handel nachbörslich:
7.00
-0.06
-0.85%
Schlusskurs vom Vortag:
$7.44
Offen:
$7.47
24-Stunden-Volumen:
1.44M
Relative Volume:
1.42
Marktkapitalisierung:
$617.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-5.3485
EPS:
-1.32
Netto-Cashflow:
$-79.09M
1W Leistung:
-0.14%
1M Leistung:
+22.78%
6M Leistung:
+101.14%
1J Leistung:
-3.68%
1-Tages-Spanne:
$6.78
$7.63
1-Wochen-Bereich:
$6.78
$7.78
52-Wochen-Spanne:
$1.865
$11.40
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Firmenname
Terns Pharmaceuticals Inc
Sektor
Branche
Telefon
650-525-5535 EXT.101
Adresse
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Vergleichen Sie TERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
7.06 | 661.58M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
| 2024-10-31 | Eingeleitet | Oppenheimer | Outperform |
| 2023-06-22 | Eingeleitet | Mizuho | Buy |
| 2023-06-07 | Eingeleitet | Jefferies | Buy |
| 2023-05-31 | Eingeleitet | ROTH MKM | Buy |
| 2023-05-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-14 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-02-07 | Eingeleitet | UBS | Buy |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-14 | Fortgesetzt | Goldman | Buy |
| 2021-03-02 | Eingeleitet | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Buy |
| 2021-03-02 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten
Historical volatility pattern of Terns Pharmaceuticals Inc. visualizedQuarterly Market Summary & Community Consensus Trade Alerts - Newser
Terns Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Using economic indicators to assess Terns Pharmaceuticals Inc. potentialMarket Movers & Accurate Buy Signal Notifications - Newser
Custom watchlist performance reports with Terns Pharmaceuticals Inc.Market Performance Recap & Real-Time Volume Trigger Notifications - Newser
Chart based analysis of Terns Pharmaceuticals Inc. trendsJuly 2025 Closing Moves & High Accuracy Trade Alerts - Newser
What makes Terns Pharmaceuticals Inc. stock price move sharplyJuly 2025 Decliners & Advanced Technical Signal Analysis - Newser
When is the best time to exit Terns Pharmaceuticals Inc.2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - Newser
Using R and stats models for Terns Pharmaceuticals Inc. forecastingEarnings Overview Report & Precise Trade Entry Recommendations - Newser
Analyzing net buyer seller activity in Terns Pharmaceuticals Inc.Quarterly Profit Summary & Smart Allocation Stock Reports - Newser
Can Terns Pharmaceuticals Inc. benefit from deglobalization2025 Bull vs Bear & Daily Stock Momentum Reports - khodrobank.com
Technical Charts Suggest Momentum Shift in Terns Pharmaceuticals Inc.Oil Prices & Stepwise Trade Signal Guides - beatles.ru
Earnings visualization tools for Terns Pharmaceuticals Inc.Analyst Downgrade & Fast Entry High Yield Stock Tips - Newser
Risk vs reward if holding onto Terns Pharmaceuticals Inc.2025 Key Highlights & Weekly High Return Stock Opportunities - Newser
Why is Terns Pharmaceuticals Inc. stock going down2025 Earnings Surprises & Real-Time Stock Price Movement Reports - khodrobank.com
Is this a good reentry point in Terns Pharmaceuticals Inc.Jobs Report & Short-Term Swing Trade Alerts - Newser
Can Terns Pharmaceuticals Inc. maintain its current growth rateRisk Management & Fast Exit and Entry Trade Guides - khodrobank.com
Analyzing Terns Pharmaceuticals Inc. with risk reward ratio charts2025 Market Sentiment & Smart Investment Allocation Tips - Newser
Is Terns Pharmaceuticals Inc. stock forming a cup and handleJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - khodrobank.com
What are Terns Pharmaceuticals Inc.’s technical support levelsJuly 2025 Movers & Fast Gaining Stock Strategy Reports - khodrobank.com
Momentum divergence signals in Terns Pharmaceuticals Inc. chartQuarterly Market Summary & Community Consensus Trade Alerts - Newser
Terns Pharmaceuticals Inc. stock chart pattern explainedDay Trade & AI Driven Stock Price Forecasts - Newser
Terns Pharmaceuticals Inc. recovery potential after sell offJuly 2025 Price Swings & Consistent Growth Equity Picks - Newser
Can trapped investors hope for a rebound in Terns Pharmaceuticals Inc.Dollar Strength & Community Supported Trade Ideas - Newser
Heatmap analysis for Terns Pharmaceuticals Inc. and competitorsWatch List & Trade Opportunity Analysis - Newser
Published on: 2025-08-30 08:46:51 - beatles.ru
Applying chart zones and confluence areas to Terns Pharmaceuticals Inc.Trade Volume Summary & Long-Term Growth Portfolio Plans - Newser
Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Terns Pharmaceuticals Inc-Aktie (TERN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gengos Andrew | Chief Financial Officer |
Jun 27 '25 |
Buy |
3.93 |
10,000 |
39,283 |
25,000 |
| Burroughs Amy L. | Chief Executive Officer |
Jun 25 '25 |
Buy |
3.87 |
23,314 |
90,230 |
47,083 |
| Gengos Andrew | Chief Financial Officer |
Jun 13 '25 |
Buy |
3.73 |
10,000 |
37,350 |
10,000 |
| Gengos Andrew | Chief Financial Officer |
Jun 16 '25 |
Buy |
3.95 |
5,000 |
19,732 |
15,000 |
| Kuriakose Emil | Chief Medical Officer |
Apr 01 '25 |
Sale |
2.49 |
952 |
2,366 |
53,317 |
| Jung Melita Sun | Chief Business Officer |
Nov 30 '24 |
Buy |
5.11 |
2,250 |
11,498 |
2,250 |
| Burroughs Amy L. | Chief Executive Officer |
Nov 30 '24 |
Buy |
5.11 |
510 |
2,606 |
19,609 |
| Kuriakose Emil | Chief Medical Officer |
Jan 02 '25 |
Sale |
5.71 |
4,481 |
25,607 |
54,269 |
| Vignola Mark J. | Chief Financial Officer |
Jan 06 '25 |
Sale |
5.80 |
9,059 |
52,500 |
74,752 |
| Vignola Mark J. | Chief Financial Officer |
Jan 02 '25 |
Sale |
5.72 |
8,129 |
46,524 |
83,811 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):